Article
Elevated cell-free mitochondria DNA level of patients with premature ovarian insufficiency
22 Jun 2023
Abstract excerpt
BACKGROUND: Premature ovarian insufficiency (POI) patients present with a chronic inflammatory state. Cell-free mitochondria DNA (cf-mtDNA) has been explored as a reliable biomarker for estimating the inflammation-related disorders, however, the cf-mtDNA levels in POI patients have never been measured. Therefore, in the presenting study, we aimed to evaluate the levels of cf-mtDNA in plasma and follicular fluid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
